Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2024-2032. Read the ...

To better meet the unique needs of the Chinese market, Roche Diagnostics leveraged its global resources and local R&D capabilities to launch the first domestically developed immunodiagnostic ...

Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD ...

QuidelOrtho Receives FDA 510(k) Clearance for its VITROS Syphilis Assay SAN DIEGO, August 29, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") has received U.S. Food ...

Founded in 2008, PCL is a leader in multiplex immunodiagnostics and has pioneered the first multiplex immunodiagnostic ...

Metabolic rewiring is essential for osteoclast differentiation and bone resorption. This study shows that glutaminolysis ...

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its VITROS syphilis assay as part of its menu ...

He also researched and developed antigens that could be used to develop immunodiagnostic kits for diagnosing infectious agents. Most recently, Dr. Tumban’s research has been focused on the development ...

They are frequently employed in the context of developing antibodies and vaccines. High-quality antigens and antibodies are also essential elements of immunodiagnostic tests.

The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms ...